 |
 |
|
|
|
|
| |
| MarketReach America Life Sciences Baltimore Conference |
| |
| |
 Upon my return from the five-day MarketReach America life sciences conference in Baltimore, Maryland, it was hard to describe the experience without reviewing the factors that combined to make it a stellar experience: fantastic presenters, unbelievable location, excellent food, and beautiful weather. So what was it really like?
|
| The Purpose |
The purpose of the conference was to help the selected Israeli companies focus on what they need to do in order to bring their products and technologies to the U.S. market. As part of the conference program, the companies reviewed and adapted their marketing strategies and plans with their entry efforts.
 Ten members of the five companies selected for the program and five MarketReach America professional staff members (Naomi Alper, shown in the picture at right, Barry Bogage, D. Todd Dollinger, Mark Dollinger, Steve Rhodes) were joined by some 60 speakers and advisors garnered from the life sciences' business world for this intensive program. The conference was held at the Mount Washington Conference Center, in Baltimore, Maryland, a facility recently acquired by Johns Hopkins University. The center provided all the services required for a conference with a level of intimacy that was very well suited to its extensive needs.
|
| The Program Structure
|
The MarketReach America Life Sciences Companies
These companies were selected on a competitive basis.
Andante has produced an advanced real-time monitoring and biofeedback systems for rehabilitation.
Chiasma has developed a drug delivery technology that permits the oral delivery of protein and peptide drugs, such as insulin and heparin, which are currently given by injection.
ETView has devised an endotracheal tube with an integral miniature video camera for visualizing and monitoring the entire intubation process.
MGVS uses a patient's own (autologous) genetically modified vascular or smooth muscle cells to induce the production and maturation of new blood vessels to bypass blocked or occluded arteries and to form linings for small caliber vascular grafts to prevent graft failure.
SLP is the world's leading manufacturer of sleep lab sensors and developer of a line of home-use sensors for the detection of sleep disorders.
|
Each day of the five-day program was divided into a number of individual (company) and group sessions that formed the structure of the well-organized conference.
- Speakers. In these formal sessions, speakers from leading biotech companies, medical product distribution, the FDA consultancies, VCs, reimbursement consultancies, and others spoke about the issues and challenges facing life sciences companies entering the U.S. market.
- Consulting sessions. Individual sessions tailored to each company were held with advisors from the field and from the business community to assist them in dealing with issues relevant to their company and to help them establish workable marketing plans.
- Off-campus visits. Each company visited sites of strategic interest to them, for example, an emergency medical center, a rehabilitation center, and a sleep lab.
- Meals. At breakfasts, lunches, and dinners, speakers joined us to talk about the State of Maryland and its institutions and organizations that assist companies in getting started.
 Other elements of the program included a formal reception and dinner sponsored by the Maryland Israel Development Center, with keynote speaker Ed Miller, deputy chief of staff of Maryland Governor Robert Ehrlich. During the dinner, each of the five companies told its story before the more than 80 illustrious guests. And a special event of the program was being treated to the uniquely American experience of watching a professional baseball game from a corporate skybox.
|
| Short-Term Results |
The five companies were exposed to an incredible number of movers and shakers. They received hands-on, personalized advice on how to proceed. They received extensive press coverage in the local press and their names were "out there" for increased awareness. They established contacts who had the ability and were only too willing to help them navigate the U.S. life sciences waters.
|
| Long-Term Results |
The long-term results of the program will not be known for months, or even years. The MarketReach America Life Sciences companies will return to the United States later in the year for their road shows to meet the prospective strategic partners and investors that this strategy conference and ongoing work in Israel has helped them to identify and focus on.
We will be in Baltimore again in July with the MarketReach America Information, Communication, and Electronic Technology (ICET) companies. Watch for details about the MarketReach America ICET companies in the next Trendletter.
|
The Trendletter team welcomes your comments.
|
Naomi Alper
Senior Project Manager
The Trendlines Group
|
|
|
|
|
©2002–2008 Trendlines International Ltd. All rights reserved.
Phone: +972.4.958.3323 | postmaster@trendlines.com
Directions |
Privacy Policy |
Site Map
This site contains material copyrighted by third parties.
This site
is best viewed in Internet Explorer version 5 or higher.
|
| |
| |
|
|
|
|
